This is a Single Ascending Dose Tolerance Study

NCT01133574 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Part A completed successfully 22 July 2010, Part B will be separate PET study

Conditions

Cognition Disorders

Interventions

DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: Placebo capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: SLV354 capsules
DRUG: Placebo capsules

Sponsor

Abbott

Collaborators

[object Object]